Innovation Pharmaceuticals Inc (IPIX)

[Cognition]

“In order to obtain maximum value of the Brilacidin-IBD asset, based on feedback from some of the world’s leading pharmaceutical companies in this therapeutic area, we plan to develop this asset as an oral dose (pill or tablet), complete a microbiome study in healthy volunteers, and perform a placebo-controlled study”.

Pure speculation
I’m guessing one of those world’s leading pharmaceutical companies described in the latest q is the same one that will be IPIX’s first partnerships for OM. IMO that’s what’s been holding up the deal. The term sheet was signed for both OM and IBD. My guess is during the negotiations IPIX didn’t like the terms of the IBD deal. So instead of bundling them together and getting less. IPIX decided to split them up and get more. Thinking long term. Thats why they locked in the laboratory for 5 years. They know they will have the funding. Because they know the OM deal is about to happen. And when IPIX’s has the funding they know that when they can they will not waste their money on another CRO that potentially could end up costing a lot more than what was initially proposed. Do what they can in-house. Building a company takes time. Building a biotech company takes even longer. Glad IPIX management is planning for the future. They wouldn’t be doing this unless they knew where their next meal was coming from. Excited for the first of many partnerships to come. JMO. gL